DNTH
Dianthus Therapeutics, Inc. · Healthcare
SVP, General Counsel and Sec. Adam M Veness sold $2.2M of Dianthus Therapeutics, Inc.
Sold$2,208,833
$110.44Price
20,000Shares
−100%Stake
What DNTH did after the filing
- The stock from Wed, Aug 12 open, $109.37
- −19.0%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Sep 25 close.
Traded Fri, Aug 7. Filed Tue, Aug 11, 5:08 PM ET, after the close. Returns use the Aug 12 open and the Sep 25 close. Not investment advice.